Acadia Pharmaceuticals ACAD Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Acadia Pharmaceuticals's invested capital?
- Acadia Pharmaceuticals (ACAD) reported invested capital of $1.02B in Q1 2026.
- How has Acadia Pharmaceuticals's invested capital changed year-over-year?
- Acadia Pharmaceuticals's invested capital increased by 68.4% year-over-year, from $603.55M to $1.02B.
- What is the long-term trend for Acadia Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's invested capital has grown at a 25.7% compound annual growth rate (CAGR), from $350.53M to $1.1B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).